Načítá se...

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma

BACKGROUND: In clinical practice, the detection of biomarkers is mostly based on primary tumors for its convenience in acquisition. However, immune checkpoints may express differently between primary and metastatic tumor. Therefore, we aimed to compare the differential expressions of PD-1, PD-L1 and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Zhang, Xingming, Yin, Xiaoxue, Zhang, Haoran, Sun, Guangxi, Yang, Yaojing, Chen, Junru, Zhu, Xudong, Zhao, Peng, Zhao, Jinge, Liu, Jiandong, Chen, Ni, Wang, Jia, Shen, Pengfei, Zeng, Hao
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6469103/
https://ncbi.nlm.nih.gov/pubmed/30992011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5578-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!